Nephrol Dial Transplant (2003) 18: 106-112
© 2003 European Renal Association-European Dialysis and Transplant Association
Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients
1 Nephrology Department, 2 Clinical Biochemistry Department, 3 Haematology Department and 4 Haemodialysis Unit, University Hospital ‘Germans Trias i Pujol’, Badalona, Universidad Autonoma de Barcelona, Barcelona, Spain
Background. Cardiovascular disease (CVD) is common in haemodialysis patients with chronic renal insufficiency and is the leading cause of death. The accelerated state of atherosclerosis found in these patients is due to a combination of different mechanisms. Recent studies confirm that inflammation plays an important role in the development of atherosclerosis. However, the role of hyperhomocysteinaemia and the immune response to oxidation of low-density lipoproteins (LDL) remains unclear and studies show contradictory results. The objective of this study was to determine whether there is a relationship between inflammation, hyperhomocysteinaemia and oxidative stress and whether these CVD risk factors are predictors of mortality in haemodialysis patients.
Methods. A prospective follow-up study was carried out in 94 stable, chronic haemodialysis patients for 24 months (July 1999–July 2001). All the patients were given folic acid and vitamin B complex supplements. Homocysteine was determined by fluorescence polarization immunoassay. C-reactive protein (CRP) levels were determined by chemiluminescent enzyme-labelled immunometric assay. Plasma copper oxidized anti-LDL (oxLDL) antibodies were measured by ELISA using native LDL and oxLDL as antigens.
Results. Thirty-two patients died during the study and 59.3% of the deaths could be attributed to CVD (eight to acute myocardial infarction and 11 to non-coronary vascular disease). The patients had slight hyperhomocysteinaemia (25.8±7.82 µmol/l), evidence of inflammation (CRP 5.16 mg/l (0.35–88.7)) and oxidative stress (oxLDL antibodies=162±77 optical density at 495 nm x1000). Age (P<0.01), CRP (P=0.03) and the oxLDL antibody titre (P<0.01) were predictive of mortality. The patients who died from heart disease showed higher oxLDL antibody titres (P=0.03). No correlation was found between homocysteine, CRP and the oxLDL antibody titre, or between serum homocysteine levels and the different causes of mortality.
Conclusions. These results suggest that lipid peroxidation and inflammation, but not hyperhomocysteinaemia, are the main risk factors for mortality in haemodialysis patients receiving vitamin supplements. As the study was carried out in a relatively limited number of patients, our findings need to be confirmed in a larger patient population.
Keywords: C-reactive protein; folic acid; haemodialysis; homocysteine; mortality; oxidized LDL antibodies
Correspondence and offprint requests to: R. Romero, Nephrology Department, University Hospital ‘Germans Trias i Pujol’, Badalona, Universidad Autonoma de Barcelona, Barcelona, Spain. Email: rromero{at}ns.hugtip.scs.es
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Stenvinkel, J. J. Carrero, J. Axelsson, B. Lindholm, O. Heimburger, and Z. Massy Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient: How Do New Pieces Fit into the Uremic Puzzle? Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 505 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. van Guldener Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1161 - 1166. [Full Text] [PDF]
|
|
|
|
|
|
B. Bayes, M. C. Pastor, J. Bonal, A. Foraster, and R. Romero Oxidative stress, inflammation and cardiovascular mortality in haemodialysis--role of seniority and intravenous ferrotherapy: analysis at 4 years of follow-up Nephrol. Dial. Transplant., April 1, 2006; 21(4): 984 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Menon, M. J. Sarnak, T. Greene, X. Wang, A. A. Pereira, G. J. Beck, J. W. Kusek, J. Selhub, A. J. Collins, A. S. Levey, et al. Relationship Between Homocysteine and Mortality in Chronic Kidney Disease Circulation, March 28, 2006; 113(12): 1572 - 1577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Suliman, P. Barany, K. Kalantar-Zadeh, B. Lindholm, and P. Stenvinkel Homocysteine in uraemia--a puzzling and conflicting story Nephrol. Dial. Transplant., January 1, 2005; 20(1): 16 - 21. [Full Text] [PDF]
|
|
|
|
|
|
P. Stenvinkel, U. Diczfalusy, B. Lindholm, and O. Heimburger Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy Nephrol. Dial. Transplant., April 1, 2004; 19(4): 972 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. McDonald, G. P. Maguire, and W. E. Hoy Renal function and cardiovascular risk markers in a remote Australian Aboriginal community Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1555 - 1561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. McDonald, G. P. Maguire, and W. E. Hoy Renal function and cardiovascular risk markers in a remote Australian Aboriginal community Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1555 - 1561. [Abstract] [Full Text]
|
|